| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.05 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |